Fagron Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "Sterile Compounding Pharmacies Market Forecast to 2028" report has been added to ResearchAndMarkets.com's...

Share this article Share this article Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners’ assessment and treatment of hair loss in the US: TrichoTest. Fagron North America. Together we create the future of personalizing medicine. AUSTIN, Texas, June 2, 2021 /PRNewswire/ -- Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners' assessment and treatment of hair loss in the US: TrichoTest.*   TrichoTest is a genetic t...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Share this article Share this article ResearchAndMarkets.com's offering. The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028. Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the fo...